Press release
August 4, 2026
Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock
Twist Bioscience Corp (TWST)
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 4, 2026-- Twist Bioscience Corporation (Nasdaq: TWST) (“Twist”), a mid-cap growth and value biotech company, today announced the commencement of an underwritten public offering of $250.0 million of shares of its common stock.